Dr. Ali S. Albaghdadi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2000 Fax: 563-243-0817 |
Dr. Thomas R Stoiber, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2009 5th St, Monroe, WI 53566 Phone: 608-324-2000 Fax: 608-324-2469 |
Arif Ahmad, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2000 |
News Archive
On the worst day of her life, Rebecca Woolf found comfort in the most unexpected way. As her husband lay dying in his hospital bed, the sound of a harp wafted in.
No one will disagree that an active lifestyle is good for you, but it remains unclear how physical activity improves brain health, particularly in Alzheimer's disease.
Merck announced today that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously that the available data support approval of Merck's investigational medicine VICTRELIS™ (boceprevir) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection in combination with current standard therapy.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 7 that the available data adequately demonstrate that the potential benefits of Contrave® (naltrexone sustained release (SR)/bupropion SR) outweigh the potential risks when used long-term in a population of overweight and obese individuals and support approval.
› Verified 2 days ago